Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.

Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T; MTN-020/ASPIRE and MTN-003/VOICE Study Teams.

AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002451. [Epub ahead of print]

PMID:
31764068
2.

Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with HIV in the United States (2005-2016).

Dionne-Odom J, Westfall AO, Dombrowski JC, Kitahata MM, Crane HM, Mugavero MJ, Moore RD, Karris M, Christopoulos K, Geng E, Mayer KH, Marrazzo J.

Clin Infect Dis. 2019 Nov 12. pii: ciz1108. doi: 10.1093/cid/ciz1108. [Epub ahead of print]

PMID:
31712815
3.

Social harms in female-initiated HIV prevention method research: state of the evidence.

Montgomery ET, Roberts ST, Nel A, Malherbe M, Torjesen K, Bunge K, Singh D, Baeten JM, Marrazzo J, Chirenje ZM, Kabwigu S, Beigi R, Riddler SA, Gaffour Z, Reddy K, Mansoor LE, Nair G, Woeber K, Moodley J, Jeenarain N, Siva S, Naidoo L, Govender V, Palanee-Phillips T.

AIDS. 2019 Nov 15;33(14):2237-2244. doi: 10.1097/QAD.0000000000002346.

PMID:
31408030
4.

Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.

Keller MJ, Wood L, Billingsley JM, Ray LL, Goymer J, Sinclair S, McGinn AP, Marzinke MA, Frank B, Srinivasan S, Liu C, Atrio JM, Espinoza L, Mugo N, Spiegel HML, Anderson PL, Fredricks DN, Hendrix CW, Marrazzo J, Bosinger SE, Herold BC.

Lancet HIV. 2019 Aug;6(8):e498-e508. doi: 10.1016/S2352-3018(19)30145-6. Epub 2019 Jul 15.

PMID:
31320290
5.

HIV Status and Other Risk Factors for Prevalent and Incident Sexually Transmitted Infection during Pregnancy (2000-2014).

Dionne-Odom J, Khan MJ, Jauk VC, Szychowski J, Long DM, Wallace S, Neely C, Fry K, Marrazzo J, Crain M, Tita ATN.

Infect Dis Obstet Gynecol. 2019 Apr 1;2019:6584101. doi: 10.1155/2019/6584101. eCollection 2019.

6.

Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.

Marrazzo JM, Rabe L, Kelly C, Richardson B, Deal C, Schwartz JL, Chirenje ZM, Piper J, Morrow RA, Hendrix CW, Marzinke MA, Hillier SL; VOICE Study Team.

J Infect Dis. 2019 May 24;219(12):1940-1947. doi: 10.1093/infdis/jiz045.

PMID:
30753642
7.

The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.

McKinnon LR, Achilles SL, Bradshaw CS, Burgener A, Crucitti T, Fredricks DN, Jaspan HB, Kaul R, Kaushic C, Klatt N, Kwon DS, Marrazzo JM, Masson L, McClelland RS, Ravel J, van de Wijgert JHHM, Vodstrcil LA, Tachedjian G.

AIDS Res Hum Retroviruses. 2019 Mar;35(3):219-228. doi: 10.1089/AID.2018.0304.

8.

Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest.

Aral SO, Bachmann LH, Marrazzo JM.

Sex Transm Dis. 2019 Jun;46(6):e65-e67. doi: 10.1097/OLQ.0000000000000969. No abstract available.

PMID:
30601376
9.

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.

Taylor SN, Marrazzo J, Batteiger BE, Hook EW 3rd, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, Mueller J.

N Engl J Med. 2018 Nov 8;379(19):1835-1845. doi: 10.1056/NEJMoa1706988.

PMID:
30403954
10.

Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.

Marrazzo JM, Dombrowski JC, Wierzbicki MR, Perlowski C, Pontius A, Dithmer D, Schwebke J.

Clin Infect Dis. 2019 Feb 15;68(5):803-809. doi: 10.1093/cid/ciy554.

12.

PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States.

Chapman Lambert C, Marrazzo J, Amico KR, Mugavero MJ, Elopre L.

J Assoc Nurses AIDS Care. 2018 Nov - Dec;29(6):835-848. doi: 10.1016/j.jana.2018.03.005. Epub 2018 Apr 5. Review.

PMID:
29685648
13.

Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening?

Dionne-Odom J, Westfall AO, Van Der Pol B, Fry K, Marrazzo J.

Sex Transm Dis. 2018 Nov;45(11):762-769. doi: 10.1097/OLQ.0000000000000852.

14.

Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic.

Tat S, Dhanireddy S, Marrazzo JM, Barbee LA.

Sex Transm Dis. 2018 Jun;45(6):417-421. doi: 10.1097/OLQ.0000000000000769.

15.

Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.

Marrazzo JM, Dombrowski JC, Mayer KH.

PLoS Med. 2018 Jan 10;15(1):e1002485. doi: 10.1371/journal.pmed.1002485. eCollection 2018 Jan.

16.

Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.

Schwebke JR, Gaydos CA, Davis T, Marrazzo J, Furgerson D, Taylor SN, Smith B, Bachmann LH, Ackerman R, Spurrell T, Ferris D, Burnham CA, Reno H, Lebed J, Eisenberg D, Kerndt P, Philip S, Jordan J, Quigley N.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01091-17. doi: 10.1128/JCM.01091-17. Print 2018 Feb.

17.

Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities.

Aberg JA, Blankson J, Marrazzo J, Adimora AA.

J Infect Dis. 2017 Sep 15;216(suppl_5):S606-S610. doi: 10.1093/infdis/jix332.

PMID:
28938047
18.

The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.

Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM; VOICE Study Team.

J Clin Virol. 2017 Sep;94:15-21. doi: 10.1016/j.jcv.2017.06.006. Epub 2017 Jun 29.

19.

Sexually transmitted infections: challenges ahead.

Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK.

Lancet Infect Dis. 2017 Aug;17(8):e235-e279. doi: 10.1016/S1473-3099(17)30310-9. Epub 2017 Jul 9. Review.

PMID:
28701272
20.

HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.

Shacklett BL, Derdeyn CA, Folayan MO, Landovitz RJ, Anthony C, Behrens AJ, Hope TJ, Landais E, Leal L, Marrazzo JM, Morris L, Mugo N, Ngure K, Noseda V, Ranasinghe S, Tully DC, Voronin Y, Warren M, Wibmer CK, Xie IY, Scarlatti G, Thyagarajan B.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):749-759. doi: 10.1089/AID.2017.0125. Epub 2017 Jul 26.

21.

Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.

Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE.

J Womens Health (Larchmt). 2017 Jun;26(6):670-676. doi: 10.1089/jwh.2016.5958. Epub 2017 Feb 17.

22.

Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.

Quilter L, Dhanireddy S, Marrazzo J.

Curr HIV/AIDS Rep. 2017 Apr;14(2):41-46. doi: 10.1007/s11904-017-0350-3. Review.

PMID:
28374281
23.

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, Gandhi M.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):778-783. doi: 10.1089/aid.2016.0202. Epub 2017 Mar 2.

24.

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA.

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

25.

HIV Prevention: Opportunities and Challenges.

Marrazzo JM.

Top Antivir Med. 2017 Dec/Jan;24(4):123-126. Review.

26.

Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).

Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J.

Sex Transm Dis. 2017 Mar;44(3):135-140. doi: 10.1097/OLQ.0000000000000568.

27.

Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.

Gaydos CA, Schwebke J, Dombrowski J, Marrazzo J, Coleman J, Silver B, Barnes M, Crane L, Fine P.

Expert Rev Mol Diagn. 2017 Mar;17(3):303-306. doi: 10.1080/14737159.2017.1282823. Epub 2017 Jan 29.

28.

Validity of self-reported history of Chlamydia trachomatis infection.

Frisse AC, Marrazzo JM, Tutlam NT, Schreiber CA, Teal SB, Turok DK, Peipert JF.

Am J Obstet Gynecol. 2017 Apr;216(4):393.e1-393.e7. doi: 10.1016/j.ajog.2016.12.005. Epub 2016 Dec 14.

29.

Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A.

AIDS Behav. 2016 Nov;20(11):2654-2661.

30.

Ocular Syphilis: a Clinical Review.

Woolston SL, Dhanireddy S, Marrazzo J.

Curr Infect Dis Rep. 2016 Nov;18(11):36. doi: 10.1007/s11908-016-0542-9. Review.

PMID:
27686678
31.

The Vaginal Microbiome: Current Understanding and Future Directions.

Martin DH, Marrazzo JM.

J Infect Dis. 2016 Aug 15;214 Suppl 1:S36-41. doi: 10.1093/infdis/jiw184.

32.

More Easily Cultivated Than Identified: Classical Isolation With Molecular Identification of Vaginal Bacteria.

Srinivasan S, Munch MM, Sizova MV, Fiedler TL, Kohler CM, Hoffman NG, Liu C, Agnew KJ, Marrazzo JM, Epstein SS, Fredricks DN.

J Infect Dis. 2016 Aug 15;214 Suppl 1:S21-8. doi: 10.1093/infdis/jiw192.

33.

Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported From a Growing Epidemic in the United States.

Marx GE, Dhanireddy S, Marrazzo JM, Tuddenham SA, Rompalo AM, Leone PA, Gaydos CA, Rietmeijer CA.

Sex Transm Dis. 2016 Aug;43(8):519-23. doi: 10.1097/OLQ.0000000000000477.

34.

Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.

Kalapila AG, Marrazzo J.

Med Clin North Am. 2016 Jul;100(4):927-50. doi: 10.1016/j.mcna.2016.03.013. Review.

PMID:
27235622
35.

The effect of complex workplace dietary interventions on employees' dietary intakes, nutrition knowledge and health status: a cluster controlled trial.

Geaney F, Kelly C, Di Marrazzo JS, Harrington JM, Fitzgerald AP, Greiner BA, Perry IJ.

Prev Med. 2016 Aug;89:76-83. doi: 10.1016/j.ypmed.2016.05.005. Epub 2016 May 18.

PMID:
27208667
36.

Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.

Gaydos CA, Hobbs M, Marrazzo J, Schwebke J, Coleman JS, Masek B, Dize L, Jang D, Li J, Chernesky M.

Sex Transm Dis. 2016 Jun;43(6):369-73. doi: 10.1097/OLQ.0000000000000447.

37.

Implementation and Operational Research: Effectiveness and Patient Acceptability of a Sexually Transmitted Infection Self-Testing Program in an HIV Care Setting.

Barbee LA, Tat S, Dhanireddy S, Marrazzo JM.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e26-31. doi: 10.1097/QAI.0000000000000979.

38.

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.

Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):333-43. doi: 10.1097/QAI.0000000000000974.

39.

Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.

Mirembe BG, Kelly CW, Mgodi N, Greenspan S, Dai JY, Mayo A, Piper J, Akello CA, Kiweewa FM, Magure T, Nakabiito C, Marrazzo JM, Chirenje ZM, Riddler SA; MTN-003B Protocol Team.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):287-94. doi: 10.1097/QAI.0000000000000858.

40.

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW; MTN-003 VOICE Protocol Team for Microbicide Trials Network.

J Int AIDS Soc. 2016 Feb 4;19(1):20642. doi: 10.7448/IAS.19.1.20642. eCollection 2016.

41.

Women Who Have Sex with Women Living in Low- and Middle-Income Countries: A Systematic Review of Sexual Health and Risk Behaviors.

Tat SA, Marrazzo JM, Graham SM.

LGBT Health. 2015 Jun;2(2):91-104. doi: 10.1089/lgbt.2014.0124. Epub 2015 Mar 26. Review.

42.

Disclosure of pharmacokinetic drug results to understand nonadherence.

van der Straten A, Montgomery ET, Musara P, Etima J, Naidoo S, Laborde N, Hartmann M, Levy L, Bennie T, Cheng H, Piper J, Grossman CI, Marrazzo J, Mensch B; Microbicide Trials Network-003D Study Team.

AIDS. 2015 Oct 23;29(16):2161-71. doi: 10.1097/QAD.0000000000000801.

43.

A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.

Hope TJ, Marrazzo JM.

AIDS Res Hum Retroviruses. 2015 Nov;31(11):1055-9. doi: 10.1089/AID.2015.0310. Review.

44.

Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.

Noguchi LM, Richardson BA, Balkus JE, Marrazzo JM.

Lancet HIV. 2015 Sep;2(9):e366-7. doi: 10.1016/S2352-3018(15)00155-1. Epub 2015 Aug 26. No abstract available.

PMID:
26423547
45.

Barriers to Bacterial Sexually Transmitted Infection Testing of HIV-Infected Men Who Have Sex With Men Engaged in HIV Primary Care.

Barbee LA, Dhanireddy S, Tat SA, Marrazzo JM.

Sex Transm Dis. 2015 Oct;42(10):590-4. doi: 10.1097/OLQ.0000000000000320.

46.

Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis.

Gorgos LM, Sycuro LK, Srinivasan S, Fiedler TL, Morgan MT, Balkus JE, McClelland RS, Fredricks DN, Marrazzo JM.

Sex Transm Dis. 2015 Sep;42(9):475-481. doi: 10.1097/OLQ.0000000000000318.

47.
48.

Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man.

Bender Ignacio RA, Koch LL, Dhanireddy S, Charmie Godornes B, Lukehart SA, Marrazzo JM.

Open Forum Infect Dis. 2015 Jun 20;2(3):ofv094. doi: 10.1093/ofid/ofv094. eCollection 2015 Sep.

49.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

50.

Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.

Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje ZM, Marrazzo JM, Brown ER.

J Infect Dis. 2016 Feb 1;213(3):335-42. doi: 10.1093/infdis/jiv333. Epub 2015 Jun 29.

Supplemental Content

Loading ...
Support Center